Tag Archives: metabolic health

Screening for fatty liver disease in patients with diabetes is no longer limited to identifying elevated liver enzymes or calculating a fibrosis score during an annual visit. Instead, clinicians are entering an era where diabetes care and hepatology increasingly overlap, especially as metabolic dysfunction-associated steatotic liver disease, or MASLD, becomes …

Prediabetes has traditionally been diagnosed during annual physical exams through fasting glucose tests or A1C measurements. However, new diabetes prevention tools and wearable technologies are rapidly changing that model. Today, wearable devices, continuous glucose monitors (CGMs), and predictive metabolic tracking tools are giving people real-time insight into their glucose patterns …

Young adults diagnosed with type 2 diabetes early in life often face a more aggressive disease course than older adults. While metformin has long served as the standard first-line therapy, many clinicians are now reconsidering whether a “metformin-first and wait” strategy is enough for this higher-risk population. As research continues …

Diabetes screening has improved over the last two decades, yet many patients still fall through the cracks. While clinicians often rely on traditional risk models that focus on obesity, age, family history, and sedentary lifestyle, not every patient with diabetes fits that familiar picture. As a result, many diabetes cases …

Everything seems to be working perfectly until it suddenly isn’t. A patient is losing weight steadily, HbA1c levels are improving, and confidence is high during every follow-up visit. Then progress slows. The scale barely changes. Blood sugar readings stop improving. Patients start asking whether the medication has stopped working, while …

Losing 30 pounds may sound like an undeniable success story. However, what if part of that weight loss comes from muscle instead of fat? As more patients use GLP-1 medications such as semaglutide and tirzepatide, clinicians are starting to ask an important question: are these drugs quietly contributing to the …

A patient starts semaglutide through a telehealth platform, receives nutrition advice from a wellness clinic, and later visits a primary care physician for worsening gastrointestinal symptoms. None of the providers can see the full treatment picture. Situations like this are becoming increasingly common as GLP-1 medications move across multiple corners …

A patient loses 30 pounds, lowers their A1C, and improves their blood pressure within months of starting a GLP-1 medication. Stories like these are hard to ignore, and they have helped fuel growing enthusiasm around drugs like Ozempic, Wegovy, and Mounjaro. Yet as prescriptions continue to expand beyond high-risk diabetes …

Can a therapy improve metabolic health even if the scale does not budge? This question is becoming increasingly relevant as clinicians observe patients benefiting from GLP-1 therapy even without significant weight loss. While weight reduction has long been a primary goal of incretin-based therapies, emerging data suggest that metabolic improvements …

Could taking a pill instead of an injection change how early people begin treatment for type 2 diabetes or obesity? In 2026, these oral GLP-1 medications are gaining attention for their simplified dosing and improved convenience. As newer formulations reduce traditional barriers, clinicians are beginning to rethink when to initiate …